Arkeon Bio is a biotechnology company that captures CO2 from industry and converts inorganic gases into organic food.
Arkeon aims to be the world's first company using gas fermentation alongside ancient microorganisms called archaea for food applications.
Arkeon was founded in 2021 by Gregor Tegl, Simon Rittmann, and Guenther Bochmann. The company is headquartered in Vienna, Austria.
Arkeon’s technology uses gas fermentation to create completely customizable protein ingredients by capturing the greenhouse gas carbon dioxide (CO2) and converting it into the 20 proteinogenic amino acids necessary for human nutrition.
Arkeon’s patented process pioneered the harnessing of carbon dioxide to make protein – through the use of archaea, a highly resilient single-celled microorganism – without genetic engineering.
Arkeon partners with companies working toward corporate sustainability, production efficiency, and developing future-focused lifestyle products. Arkeon's 20 amino acids can be customized to enhance flavors in foods and create new ones.
Arkeon is backed by Blue Horizon, ICL, Square One Foods, Synthesis Capital, ReGen Ventures, Gründerfonds (aws Founders Fund), FoodHack, Tet Ventures, and others. The company raised €2.75M ($3M) in a new round on Jan 19, 2023. This brings Arkeon's total funding to €13.25M ($14.6M) to date.
